Evaluation of the efficacy of hydroxychloroquine in decreasing immune activation and viral replication in asymptomatic human immunodeficiency virus (HIV)-infected patients.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Hydroxychloroquine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms HCQ-01
- 25 Jul 2012 Status changed from active, no longer recruiting to completed.
- 25 Jul 2012 Primary endpoint 'CD8+-cell-count' has not been met.
- 25 Jul 2012 Results published in the JAMA: the Journal of the American Medical Association.